Finance

Lists
PMN:NASDAQ
Promis Neurosciences Inc
12,60 USD
-3,45%
(-0,45) 1D
12,50 USD
-0,79% (-0,10)
After hours
Closed: 4-сен., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PMN...
Open
13,03 USD
High
13,46 USD
Low
12,48 USD
Mkt. cap
112,99 млн
Avg. vol.
102,08 миң
Volume
24,09 миң
52-wk high
27,20 USD
52-wk low
6,27 USD
EPS
-12,61 USD
Beta
-0,20
Shares outstanding
8,97 млн
No. of employees
11
Open
13,03 USD
High
13,46 USD
Low
12,48 USD
Mkt. cap
112,99 млн
Avg. vol.
102,08 миң
Volume
24,09 миң
52-wk high
27,20 USD
52-wk low
6,27 USD
EPS
-12,61 USD
Beta
-0,20
Shares outstanding
8,97 млн
No. of employees
11
About Promis Neurosciences Inc
CEO-
Employees11
Founded2005
HeadquartersМиссисога, Онтарио, Канада
Sector-
Websitepromisneurosciences.com
Analyst ratings
Based on 6 analysts giving stock ratings to PMN in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for PMN in the last 3 months.
Highest
Current 12,60 USD
100,00 USD (+693,65%)
Average
42,46 USD (+236,98%)
Lowest
18,00 USD (+42,86%)
Analyst
Recommendation
Action
Price target
Projected
Date
Boobalan Pachaiyappan
Roth MKM
Buy
Reiterated
29,00 USD
+130,2%
08/21/2026
Jason McCarthy
Maxim Group
Buy
Maintained
35,00 USD
+177,8%
08/14/2026
Eddie Hickman
Guggenheim
Buy
Reiterated
100,00 USD
+693,7%
08/14/2026
Keay Nakae
Chardan Capital
Buy
Maintained
33,00 USD
+161,9%
08/13/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
18,00 USD
+42,9%
07/15/2026
Unknown Analyst
Guggenheim
Buy
Maintained
35,00 USD
+177,8%
07/14/2026
Pete Stavropoulos
Cantor Fitzgerald
Buy
Initiated
39,75 USD
+215,5%
06/29/2026
Unknown Analyst
Brookline Capital Markets
Buy
Initiated
40,00 USD
+217,5%
05/20/2026
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
-
-
-
-
Cost of goods sold
9,80 млн
9,37 млн
-
9,52 млн
Cost of revenue
9,80 млн
9,37 млн
-
9,52 млн
Research and development expenses
-
-
6,97 млн
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,95 млн
1,40 млн
1,67 млн
2,74 млн
Operating expense
1,95 млн
1,40 млн
8,64 млн
2,74 млн
Total operating expenses
11,75 млн
10,77 млн
8,64 млн
12,27 млн
Operating income
-11,75 млн
-10,77 млн
-8,64 млн
-12,27 млн
Other non operating income
170,31 миң
98,03 миң
400,52 миң
536,74 миң
EBT including unusual items
-11,58 млн
-10,67 млн
-8,24 млн
-11,73 млн
EBT excluding unusual items
-11,58 млн
-10,67 млн
-8,24 млн
-11,73 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-11,58 млн
-10,67 млн
-8,24 млн
-11,73 млн
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору